[NCHHSTP] The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)

ICR 202512-0920-007

OMB: 0920-1357

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Modified
Form
Modified
Form and Instruction
Modified
Form
Modified
Form
Removed
Form and Instruction
Removed
Form
Removed
Form and Instruction
Modified
Form and Instruction
Modified
Form and Instruction
Modified
Form
Modified
Form and Instruction
Modified
Supplementary Document
2026-01-13
Supplementary Document
2025-12-22
Supplementary Document
2025-12-22
Supplementary Document
2025-12-22
Supplementary Document
2025-12-22
Supplementary Document
2024-11-17
Supplementary Document
2024-11-17
Justification for No Material/Nonsubstantive Change
2024-11-17
Supplementary Document
2023-11-02
Supplementary Document
2023-11-02
Justification for No Material/Nonsubstantive Change
2023-11-02
Justification for No Material/Nonsubstantive Change
2022-09-13
Supplementary Document
2022-09-13
Supplementary Document
2022-09-09
Supplementary Document
2022-09-09
Supporting Statement B
2025-12-22
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supplementary Document
2021-06-16
Supporting Statement A
2025-12-22
ICR Details
0920-1357 202512-0920-007
Received in OIRA 202411-0920-009
HHS/CDC 0920-25-0177
[NCHHSTP] The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)
Reinstatement without change of a previously approved collection   No
Regular 01/13/2026
  Requested Previously Approved
36 Months From Approved
423 0
49 0
0 0

The purpose of this information collection is to determine the acceptability and feasibility of NATs that are used at the point-of-care (POC NAT) implementation in clinical and community settings. POC NATs have the potential to help address some of the remaining challenges to ending the HIV epidemic in the United States by assisting with early detection of acute HIV infection and by providing a more efficient viral load monitoring tool for people living with HIV. This study is the first of its kind in the US and is critical to understanding the utility of rapid point-of-care (POC) nucleic acid tests (NAT) and provider and patient perspectives on its use in the US.

US Code: 42 USC 241 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  90 FR 1501 01/08/2025
90 FR 59831 12/22/2025
No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 423 0 0 423 -474 474
Annual Time Burden (Hours) 49 0 0 49 -101 101
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a reinstatment of a collection that expried on 12/21/2024 seeking three years of approval.

$346,459
Yes Part B of Supporting Statement
    No
    No
No
No
No
No
Odion Clunis 770 488-0045 lta2@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/13/2026


© 2026 OMB.report | Privacy Policy